Testing effectiveness (Phase 2)Study completedNCT01619969What this trial is testingCelgosivir as a Treatment Against DengueWho this might be right forDengue Fever Singapore General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00730288What this trial is testingStudy of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsWho this might be right forDengueDengue FeverDengue Hemorrhagic Fever+1 more Sanofi 35
Not applicableLooking for participantsNCT07358910What this trial is testingRisk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveWho this might be right forDengueChikungunyaZika Virus Infection+55 more Institut Pasteur du Cambodge 10,000
Early research (Phase 1)Study completedNCT02743455What this trial is testingA Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy VolunteersWho this might be right forYellow FeverYellow Fever Immunisation National Institute of Allergy and Infectious Diseases (NIAID) 92
Not applicableStudy completedNCT04514107What this trial is testingA Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)Who this might be right forDengue Fever National Institute of Allergy and Infectious Diseases (NIAID) 5,757
Not applicableStudy completedNCT03956836What this trial is testingPerioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)Who this might be right forCoagulation DisorderCarcinomatosis Hospitales Universitarios Virgen del Rocío 46
Not applicableStudy completedNCT03641339What this trial is testingDefining Skin Immunity of a Bite of Key Insect Vectors in HumansWho this might be right forZikaDengueMalaria+2 more National Institute of Allergy and Infectious Diseases (NIAID) 95
Very early researchStudy completedNCT04754776What this trial is testingSafety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)Who this might be right forRift Valley Fever University of Oxford 15
Early research (Phase 1)Study completedNCT00920517What this trial is testingSafety and Immune Response to Two Doses of rDEN2/4delta30 Dengue VaccineWho this might be right forDengue Fever National Institute of Allergy and Infectious Diseases (NIAID) 25
Large-scale testing (Phase 3)Looking for participantsNCT07576868What this trial is testingCP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)Who this might be right forDengue Hyundai Bioscience Co., Ltd. 210
Early research (Phase 1)Study completedNCT04786457What this trial is testingADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)Who this might be right forDengue University of Maryland, Baltimore 10
Not applicableLooking for participantsNCT07627399What this trial is testingEffectiveness of Best Care Practices in Acute Stroke in Conventional Hospitalization (BEST CARE ICTUS_HC)Who this might be right forStrokeAcute StrokeIschemic Stroke+6 more University of Malaga 700
Large-scale testing (Phase 3)UnknownNCT05447377What this trial is testingSII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy InfantsWho this might be right forYellow Fever Serum Institute of India Pvt. Ltd. 2,216
Testing effectiveness (Phase 2)Study completedNCT02193087What this trial is testingSafety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)Who this might be right forDengue Fever Takeda 1,002
Early research (Phase 1)Study completedNCT00089908What this trial is testingSafety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy AdultsWho this might be right forDengue Fever National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT06998004What this trial is testingA Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy AdultsWho this might be right forYellow FeverRabies AstriVax Therapeutics 112
Early research (Phase 1)Study completedNCT03583606What this trial is testingA Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)Who this might be right forEbola DiseaseImmunisation National Institute of Allergy and Infectious Diseases (NIAID) 61
Testing effectiveness (Phase 2)Study completedNCT02628444What this trial is testingImmunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of AgeWho this might be right forDengue FeverDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 1,050
Early research (Phase 1)Study completedNCT01353040What this trial is testingSafety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg VirusWho this might be right forMarburg Hemorrhagic Fever Sarepta Therapeutics, Inc. 30
Early research (Phase 1)Study completedNCT03869060What this trial is testingExpansion of a Dengue-1 Live Virus Human ChallengeWho this might be right forDengue State University of New York - Upstate Medical University 9